Marshall Wace’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,055,389
Closed -$9.32M 3525
2025
Q3
$9.32M Buy
1,055,389
+787,056
+293% +$5.86M 0.01% 937
2025
Q2
$1.11M Sell
268,333
-1,957,261
-88% -$12.3M ﹤0.01% 1798
2025
Q1
$13.4M Buy
2,225,594
+1,431,953
+180% +$8.75M 0.02% 663
2024
Q4
$4.1M Buy
+793,641
New +$3.13M ﹤0.01% 1149
2024
Q3
Sell
-74,814
Closed -$223K 2996
2024
Q2
$223K Buy
74,814
+2,549
+4% +$21K ﹤0.01% 2263
2024
Q1
$853K Buy
+72,265
New +$835K ﹤0.01% 1721
2022
Q3
Sell
-913
Closed -$13K 3834
2022
Q2
$13K Buy
+913
New +$14.5K ﹤0.01% 3362
2019
Q2
Sell
-8,987
Closed -$319K 1880
2019
Q1
$319K Buy
+8,987
New +$355K ﹤0.01% 1248

Other funds holding VSTM

Marshall Wace's VSTM Position: Q4 2025 in Review

Marshall Wace sold out of Verastem (VSTM) in Q4 2025, closing a stake of 1,055,389 shares — an estimated $9.32M sold.

Marshall Wace first reported a position in VSTM in Q1 2019 and held it in 8 quarters. The position peaked at $13.4M in Q1 2025. 143 funds tracked by Wall St. Rank hold VSTM as of Q4 2025.

  • Marshall Wace reported no remaining Verastem position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 1,055,389 Verastem shares in Q4 2025, an estimated $9.32M.
  • Marshall Wace first reported a position in Verastem in Q1 2019 and held it in 8 quarters.
  • Marshall Wace's Verastem position peaked at $13.4M in Q1 2025.
  • 143 funds tracked by Wall St. Rank held Verastem as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.